Assessment of Tocilizumab (Anti-IL-6 Receptor Monoclonal) as a Potential Treatment for Chronic Antibody Mediated Rejection and Transplant Glomerulopathy in HLA Sensitized Renal Allograft Recipients

Systemic Lupus Erythematosus

Characterisation of anifrolumab, a fully human anti-interferon receptor antagonist antibody for the treatment of systemic lupus erythematosus

Lupus Sci Med.

Riggs JM, Hanna RN, Rajan B, Zerrouki K, Karnell JL, Sagar D, Vainshtein I, Farmer E, Rosenthal K, Morehouse C, de Los Reyes M, Schifferli K, Liang M, Sanjuan MA, Sims GP, Kolbeck R

doi: 10.1136/

Rheumatoid Arthritis

Assessment of the association of baseline anti-CarbV and anti-MCV antibodies with response to treatment and radiographic progression in an RA population treated with either methotrexate or baricitinib: post-hoc analyses from RA-BEGIN

Arthritis Res Ther.

López-Romero P, Martinez-Gamboa L, Bang H, de la Torre I, Holzkämper T, Feist E

doi: 10.1186/s13075-020-02284-y.

Psoriasis

Secukinumab, a fully human anti-interleukin-17A monoclonal antibody, exhibits low immunogenicity in psoriasis patients treated up to 5 years

J Eur Acad Dermatol Venereol.

Reich K, Blauvelt A, Armstrong A, Langley RG, de Vera A, Kolbinger F, Spindeldreher S, Ren M, Bruin G

doi: 10.1111/jdv.15637.

T Cells

T-Cell Reconstitution after Lymphocyte Depletion Features a Different Pattern of Inhibitory Receptor Expression in ABO- Versus HLA-Incompatible Kidney Transplant Recipients

Clin Exp Immunol.

Del Bello A, Kamar N, Treiner E

doi: 10.1111/cei.13412.

PsoriasisPsoriatic Arthritis

Association Between Early Severe Cardiovascular Events and the Initiation of Treatment With the Anti-Interleukin 12/23p40 Antibody Ustekinumab

JAMA Dermatol.

Poizeau F, Nowak E, Kerbrat S, Le Nautout B, Droitcourt C, Drici MD, Sbidian E, Guillot B, Bachelez H, Ait-Oufella H, Happe A, Oger E, Dupuy A

doi: 10.1001/jamadermatol.2020.2977.

Rheumatoid Arthritis

Profile of sarilumab and its potential in the treatment of rheumatoid arthritis

Drug Des Devel Ther.

Raimondo MG, Biggioggero M, Crotti C, Becciolini A, Favalli EG

doi: 10.2147/

Rheumatoid Arthritis

Tocilizumab modulates serum levels of adiponectin and chemerin in patients with rheumatoid arthritis: potential cardiovascular protective role of IL-6 inhibition

Clin Exp Rheumatol.

Fioravanti A, Tenti S, Bacarelli MR, Damiani A, Li Gobbi F, Bandinelli F, Cheleschi S, Galeazzi M, Benucci M

Psoriasis

First-in-human study demonstrating the safety and clinical efficacy of novel anti-IL-17A monoclonal antibody CJM112 in moderate to severe plaque psoriasis

J Eur Acad Dermatol Venereol

Kaul M, Jarvis P, Rozenberg I, Kolbinger F, Di Padova F, Calonder C, Espie P, Rondeau JM, Cebe R, Huber T, Mussmann R, Aassi M, Sligh TS

doi: 10.1111/jdv.17071

Juvenile Idiopathic Arthritis

A peptide-based anti-Adalimumab antibody assay to monitor immune response to biologics treatment in juvenile idiopathic arthritis and childhood chronic non-infectious uveitis

Sci Rep

Rusche H, Marrani E, Real-Fernandez F, Ponti R, Terzani F, Maccora I, Monasson O, Mastrolia MV, Peroni E, Pagnini I, Cimaz R, Papini AM, Simonini G, Rovero P

doi: 10.1038/s41598-021-95920-9

Related content

Characterisation of anifrolumab, a fully human anti-interferon receptor antagonist antibody for the treatment of systemic lupus erythematosus

Assessment of the association of baseline anti-CarbV and anti-MCV antibodies with response to treatment and radiographic progression in an RA population treated with either methotrexate or baricitinib: post-hoc analyses from RA-BEGIN

Secukinumab, a fully human anti-interleukin-17A monoclonal antibody, exhibits low immunogenicity in psoriasis patients treated up to 5 years

T-Cell Reconstitution after Lymphocyte Depletion Features a Different Pattern of Inhibitory Receptor Expression in ABO- Versus HLA-Incompatible Kidney Transplant Recipients

Association Between Early Severe Cardiovascular Events and the Initiation of Treatment With the Anti-Interleukin 12/23p40 Antibody Ustekinumab

Profile of sarilumab and its potential in the treatment of rheumatoid arthritis

Tocilizumab modulates serum levels of adiponectin and chemerin in patients with rheumatoid arthritis: potential cardiovascular protective role of IL-6 inhibition

First-in-human study demonstrating the safety and clinical efficacy of novel anti-IL-17A monoclonal antibody CJM112 in moderate to severe plaque psoriasis

A peptide-based anti-Adalimumab antibody assay to monitor immune response to biologics treatment in juvenile idiopathic arthritis and childhood chronic non-infectious uveitis